The catheter based treatment of structural heart diseases leads the industry to present new concepts in engineering employing novel designs, drug delivery technologies (for stents & balloons) and affordable catheter-based systems.
Today a portfolio of cleverly iterated devices ranging from access to treatment devises such as wireguides, catheters, introducers, low injury coronary stents; a Bioresorbable Scaffold; a morphology-modifying balloon catheter, a tissue covered stent graft and a Transcatheter Aortic Valves Replacement system (TAVI)